In Response
- PMID: 33031679
- DOI: 10.1213/ANE.0000000000004886
In Response
Comment on
-
Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.Anesth Analg. 2020 Mar;130(3):740-751. doi: 10.1213/ANE.0000000000004384. Anesth Analg. 2020. PMID: 31490252 Clinical Trial.
-
Fibrinogen Concentrate Compared to Cryoprecipitate to Reduce Transfusion in Infants Undergoing Cardiac Surgery: How Confident Can We Be?Anesth Analg. 2020 Aug;131(2):e83-e84. doi: 10.1213/ANE.0000000000004885. Anesth Analg. 2020. PMID: 33031678 No abstract available.
References
-
- Grocott HP, Jones PMFibrinogen concentrate compared to cryoprecipitate to reduce transfusion in infants undergoing cardiac surgery: how confident can we be? Anesth Analg. 2020;131:e83–e84.
-
- Downey LA, Andrews J, Hedlin H, et al.Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: a prospective randomized controlled trial. Anesth Analg. 2020;130:740–751.
-
- Alsoufi B, Deshpande S, McCracken C, et al.Outcomes and risk factors for heart transplantation in children with congenital heart disease. J Thorac Cardiovasc Surg. 2015;150:1455.e3–1462.e3.
-
- Fleming TR, Odem-Davis K, Rothmann MD, Li Shen YSome essential considerations in the design and conduct of non-inferiority trials. Clin Trials. 2011;8:432–439.
-
- Callum J, Farkouh ME, Scales DC, et al.Effect of fibrinogen concentrate vs cryoprecipitate on blood component transfusion after cardiac surgery: the FIBRES randomized clinical trial. JAMA. 2019;322:1966–1976.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
